These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 36644559)

  • 1. Tamoxifen-independent Cre-activity in
    Steffensen LB; Stubbe J; Overgaard M; Larsen JH
    Atheroscler Plus; 2022 Apr; 48():8-11. PubMed ID: 36644559
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Roles of vascular endothelial and smooth muscle cells in the vasculoprotective effect of insulin in a mouse model of restenosis.
    Mori Y; Gonzalez Medina M; Liu Z; Guo J; Dingwell LS; Chiang S; Kahn CR; Husain M; Giacca A
    Diab Vasc Dis Res; 2021; 18(3):14791641211027324. PubMed ID: 34190643
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A New Autosomal
    Deaton RA; Bulut G; Serbulea V; Salamon A; Shankman LS; Nguyen AT; Owens GK
    Arterioscler Thromb Vasc Biol; 2023 Feb; 43(2):203-211. PubMed ID: 36519470
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Generation and Comparative Analysis of an
    Warthi G; Faulkner JL; Doja J; Ghanam AR; Gao P; Yang AC; Slivano OJ; Barris CT; Kress TC; Zawieja SD; Griffin SH; Xie X; Ashworth A; Christie CK; Bryant WB; Kumar A; Davis MJ; Long X; Gan L; Belin de Chantemele EJ; Lyu Q; Miano JM
    Nat Cardiovasc Res; 2022 Nov; 1(11):1084-1100. PubMed ID: 36424917
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Generation of a Mouse Model with Smooth Muscle Cell Specific Loss of the Expression of PPARγ.
    Rautureau Y; Paradis P; Schiffrin EL
    Methods Mol Biol; 2017; 1527():381-407. PubMed ID: 28116732
    [TBL] [Abstract][Full Text] [Related]  

  • 6. High-fidelity
    Ackermann AM; Zhang J; Heller A; Briker A; Kaestner KH
    Mol Metab; 2017 Mar; 6(3):236-244. PubMed ID: 28271030
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Temporally controlled somatic mutagenesis in smooth muscle.
    Kühbandner S; Brummer S; Metzger D; Chambon P; Hofmann F; Feil R
    Genesis; 2000 Sep; 28(1):15-22. PubMed ID: 11020712
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Development of a smooth muscle-targeted cre recombinase mouse reveals novel insights regarding smooth muscle myosin heavy chain promoter regulation.
    Regan CP; Manabe I; Owens GK
    Circ Res; 2000 Sep; 87(5):363-9. PubMed ID: 10969033
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Optimizing tamoxifen-inducible Cre/loxp system to reduce tamoxifen effect on bone turnover in long bones of young mice.
    Zhong ZA; Sun W; Chen H; Zhang H; Lay YE; Lane NE; Yao W
    Bone; 2015 Dec; 81():614-619. PubMed ID: 26232373
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Tamoxifen-independent recombination in the RIP-CreER mouse.
    Liu Y; Suckale J; Masjkur J; Magro MG; Steffen A; Anastassiadis K; Solimena M
    PLoS One; 2010 Oct; 5(10):e13533. PubMed ID: 21063464
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Oral and Injected Tamoxifen Alter Adult Hippocampal Neurogenesis in Female and Male Mice.
    Smith BM; Saulsbery AI; Sarchet P; Devasthali N; Einstein D; Kirby ED
    eNeuro; 2022; 9(2):. PubMed ID: 35387845
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A mouse model with tamoxifen-inducible thyrocyte-specific cre recombinase activity.
    Undeutsch H; Löf C; Offermanns S; Kero J
    Genesis; 2014 Apr; 52(4):333-40. PubMed ID: 24395757
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Direct hematological toxicity and illegitimate chromosomal recombination caused by the systemic activation of CreERT2.
    Higashi AY; Ikawa T; Muramatsu M; Economides AN; Niwa A; Okuda T; Murphy AJ; Rojas J; Heike T; Nakahata T; Kawamoto H; Kita T; Yanagita M
    J Immunol; 2009 May; 182(9):5633-40. PubMed ID: 19380810
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Gcg
    Shiota C; Prasadan K; Guo P; Fusco J; Xiao X; Gittes GK
    Diabetologia; 2017 Dec; 60(12):2399-2408. PubMed ID: 28884202
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Tamoxifen-independent recombination of reporter genes limits lineage tracing and mosaic analysis using CreER
    Álvarez-Aznar A; Martínez-Corral I; Daubel N; Betsholtz C; Mäkinen T; Gaengel K
    Transgenic Res; 2020 Feb; 29(1):53-68. PubMed ID: 31641921
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Local Cre-mediated gene recombination in vascular smooth muscle cells in mice.
    Zadelaar SM; Boesten LS; Pires NM; van Nieuwkoop A; Biessen EA; Jukema W; Havekes LM; van Vlijmen BJ; Willems van Dijk K
    Transgenic Res; 2006 Feb; 15(1):31-6. PubMed ID: 16475008
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Site- and time-specific gene targeting in the mouse.
    Metzger D; Chambon P
    Methods; 2001 May; 24(1):71-80. PubMed ID: 11327805
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Genetic inducible fate mapping in adult mice using tamoxifen-dependent Cre recombinases.
    Feil S; Krauss J; Thunemann M; Feil R
    Methods Mol Biol; 2014; 1194():113-39. PubMed ID: 25064100
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Induction of whole-body gene deletion
    Kumar R; Mao Y; Patial S; Saini Y
    Front Pharmacol; 2022; 13():1018798. PubMed ID: 36569322
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparison of the
    Lesaffer B; Verboven E; Van Huffel L; Moya IM; van Grunsven LA; Leclercq IA; Lemaigre FP; Halder G
    Cells; 2019 Apr; 8(4):. PubMed ID: 31027317
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.